Showing results (2241-2250 of 6,739) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|August 6, 2020
Invasive Micropapillary Carcinoma with CEP17 Monosomy of the Bilateral Breast: A Rare Case Report and Review of the LiteratureLe Zhang, Yuechen Wang, Leichao Zhang, et al.
Oncotargets and Therapy|August 6, 2020
Clinical Significance of ZNF711 in Human Breast CancerXiaoyan Li, Liu Tian, Lina Zhang, et al.
Oncotargets and Therapy|March 29, 2021
The Association Between Inflammation and Immunosuppression: Implications for ICI Biomarker DevelopmentDanielle Benedict Sacdalan, Josephine Anne Lucero
Oncotargets and Therapy|April 10, 2023
Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast CancerRevathi Badiginchala, Palanki Satya Dattatreya, Attili Venkata Satya Suresh, et al.
Oncotargets and Therapy|April 1, 2021
A Rare Case of Primary Signet-Ring Cell Cervical Carcinoma: Early Stage with Independent Bilateral Ovarian MetastasesShiyun Li, Fuqiang Gan, Manling Luo, et al.
Oncotargets and Therapy|July 9, 2020
A Novel Circular RNA, circ_0005394, Predicts Unfavorable Prognosis and Contributes to Hepatocellular Carcinoma Progression by Regulating miR-507/E2F3 and miR-515-5p/CXCL6 Signaling PathwaysChengming Sun, Guodong Li, Ming Liu
Oncotargets and Therapy|July 9, 2020
miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2Xiyong Wang, Huaiqing Xiao, Dongqiang Wu, et al.
Oncotargets and Therapy|July 9, 2020
GOLPH3 Promotes Angiogenesis of Lung Adenocarcinoma by Regulating the Wnt/β-Catenin Signaling PathwayCanjun Zhao, Jin Zhang, Litian Ma, et al.
Oncotargets and Therapy|March 14, 2015
Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthaseMalyn M Asuncion Valenzuela, Imilce Castro, Amber Gonda, et al.
Oncotargets and Therapy|March 14, 2015
Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancerXiao-Qing Jia, Qi Hong, Jing-Yi Cheng, et al.
Pageof 674